IL-33

IL-33

IL-33 Overview

Molecule Name
Interleukin-33
Synonyms
IL33,DV27,C9ORF26,IL1F11,NFHEV,DKFZp586H0523,DVS27,NFEHEV,RP11-575C20.2
Drug Development Progress
Drugs in Clinical Trials9
Approved Drugs0
Highest Development StagePhase 3 Clinical
Target Synonym
Nuclear Factor For High Endothelial Venules,DVS27-Related Protein,IL1F11,IL33,Interleukin-1 family member 11,IL-1F11,Interleukin 33,Nuclear Factor From High Endothelial Venules,C9orf26,NF-HEV,Chromosome 9 Open Reading Frame 26 (NF-HEV),Interleukin-1 Family, Member 11,NFEHEV,DVS27,IL-33,NFHEV,Interleukin-33,DKFZp586H0523
Background
Interleukin 33 (IL33) is known as C9orf26, DKFZp586H0523, DVS27, NF-HEV, NFEHEV, RP11-575C20.2,and is a cytokine belonging to the IL-1 superfamily. IL-33 induces helper T cells, mast cells, eosinophils and basophils to produce type 2 cytokines. IL-33 mediates its biological effects by interacting with the receptors ST2 (aka IL1RL1) and IL-1 Receptor Accessory Protein (IL1RAP), activating intracellular molecules in the NF-κB and MAP kinase signaling pathways that drive production of type 2 cytokines (e.g. IL-5 and IL-13) from polarized Th2 cells. In vivo, IL-33 induces the expression of IL-4, IL-5, and IL-13 and leads to severe pathological changes in mucosal organs.

IL-33 Product List

Species
  • Human(7)
  • Cynomolgus(3)
  • Mouse(2)
Tag
  • His Tag(7)
  • His Tag & Avi Tag(5)
Host
  • HEK293(11)
  • E. coli(1)
Conjugate
  • Unconjugated(7)
  • Biotin-labeled(5)
Grade
  • RUO(12)
Low Endotoxin
  • Yes(3)
  • No(9)
MoleculeCat. No.Product NameSpeciesHostStructurePurityActivitySize&Price
IL-33
Cynomolgus IL-33 Protein, His Tag (Mass Spec & MALS verified)
Cynomolgus
HEK293
MALSSDS-PAGE
ELISABLI

$395.00

50ug
IL-33
Human IL-33 (C208S, C227S, C232S, C259S) Protein, His Tag, low endotoxin (Mass Spec & MALS verified)
Human
HEK293
MALSSDS-PAGE
ELISABLICELL BASE

$400.00

50ug
IL-33
HOTAvitag
IL3-H82H5
Biotinylated Human IL-33 Protein, His,Avitag™ (MALS verified)
Human
HEK293
MALSSDS-PAGE
ELISABLI

$395.00

25ug
IL-33
Human IL-33 Protein, His Tag (Mass Spec & HPLC verified)
Human
HEK293
HPLCSDS-PAGE
ELISABLICELL BASE

$415.00

50ug
IL-33
Cynomolgus IL-33 Protein, His Tag, Ultra Low Endotoxin (MALS verified)
Cynomolgus
HEK293
MALSSDS-PAGE
ELISA

$430.00

100ug
IL-33
Avitag
IL3-C82E3
Biotinylated Cynomolgus IL-33 Protein, His,Avitag™ (HPLC verified)
Cynomolgus
HEK293
HPLCSDS-PAGE
ELISABLI

$350.00

25ug
IL-33
Human IL-33 (2-270) Protein, His Tag
Human
E. coli
SDS-PAGE
ELISABLI

$400.00

50ug
IL-33
Human IL-33 (C208S, C259S) Protein, His Tag (MALS verified)
Human
HEK293
MALSSDS-PAGE
ELISABLICELL BASE

$360.00

50ug
IL-33
Avitag
IL3-H82E6
Biotinylated Human IL-33 (C208S, C259S) Protein, His,Avitag™ (HPLC verified)
Human
HEK293
HPLCSDS-PAGE
ELISA

$360.00

25ug
IL-33
Avitag
IL3-H82E7
Biotinylated Human IL-33 (C208S, C227S, C232S, C259S) Protein, His,Avitag™ (MALS verified)
Human
HEK293
MALSSDS-PAGE
ELISA

$360.00

25ug
You Have Viewed 1-10 Of 12 Results
  • 1
  • 2

Can’t find what you need?

Submit your requirements and our technical
team will help.

Asset Licensing Opportunity
Resources

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
TozorakimabMEDI-3506Phase 3 ClinicalMedimmune
Asthma; Bronchitis, Chronic; Dermatitis, Atopic; Diabetic Nephropathies; Pneumonia, Viral; Pulmonary Disease, Chronic Obstructive
Details
ItepekimabREGN-3500; SAR-440340Phase 3 ClinicalRegeneron Pharmaceuticals Inc, Sanofi
Asthma; Bronchiectasis; Chronic rhinosinusitis with nasal polyps (CRSwNP); Dermatitis, Atopic; Nasal Polyps; Pulmonary Disease, Chronic Obstructive; Sinusitis
Details
EtokimabANB-020Phase 2 ClinicalAnaptysbio Inc
Asthma; Dermatitis, Atopic; Hypersensitivity; Peanut Hypersensitivity; Pulmonary Eosinophilia; Sinusitis
Details
MT-2990MT-2990Phase 2 ClinicalMitsubishi Tanabe Pharma Corp
Endometriosis; Pain; Rhinitis, Allergic, Seasonal; Vasculitis
Details
GSK-3862995GSK-3862995B; GSK3862995; GSK-3862995; GSK3862995BPhase 2 ClinicalGlaxosmithkline Plc
Bronchiectasis; Pulmonary Disease, Chronic Obstructive
Details
OmpekimigPF-07264660Phase 2 ClinicalPfizer Inc
Dermatitis, Atopic
Details
SSGJ-621SSGJ-621; 621Phase 1 ClinicalSunshine GuoJian Pharmaceutical (Shanghai) Co Ltd
Asthma; Pulmonary Disease, Chronic Obstructive
Details
CAN-10CAN-10Phase 1 ClinicalLund University Foundation
Myocarditis; Plaque psoriasis; Scleroderma, Systemic
Details
QX-007NQX-007NPhase 1 ClinicalQyuns Therapeutics Co Ltd
Asthma; Pulmonary Disease, Chronic Obstructive
Details
Customer Reviews
  • 1***62019-09-26
    I used this protein to explore and establish experimental methods to do antibody screening. The experimental methods that I used include Elisa, flow cytometry, octet determination of antibody binding and competition experiments. The protein works well, the experiments results met my expectations. I buy ACRO's protein frequently.